Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The RECAPACITA project: Description of the clinical, neuropsychological and functional profile of a sample of people with severe mental disorder and legal capacity modification in Spain.
Marcó-García S, Guilera G, Ferrer-Quintero M, Ochoa S, Escuder-Romeva G, Martínez-Mondejar A, Montalbán-Roca V, Del Cacho N, Rubio-Abadal E, Escanilla-Casal A, Martínez-Zambrano F, Balsells-Mejía S, Huerta-Ramos E. Marcó-García S, et al. Int J Law Psychiatry. 2023 May-Jun;88:101874. doi: 10.1016/j.ijlp.2023.101874. Epub 2023 Mar 22. Int J Law Psychiatry. 2023. PMID: 36963181
Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
Huerta-Ramos E, Labad J, Cobo J, Núñez C, Creus M, García-Parés G, Cuadras D, Franco J, Miquel E, Reyes JC, Marcó-García S; RALOPSYCAT Group; Usall J. Huerta-Ramos E, et al. Among authors: marco garcia s. Eur Arch Psychiatry Clin Neurosci. 2020 Sep;270(6):729-737. doi: 10.1007/s00406-019-01079-w. Epub 2019 Nov 14. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 31728631 Clinical Trial.
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.
Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos E, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J; m-Resist group; Grasa EM. Alonso-Solís A, et al. Among authors: marco garcia s. BMJ Open. 2018 Jul 16;8(7):e021346. doi: 10.1136/bmjopen-2017-021346. BMJ Open. 2018. PMID: 30012788 Free PMC article.
m-RESIST, a complete m-Health solution for patients with treatmentresistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area.
Huerta-Ramos E, Marcó-García S, Escobar-Villegas MS, Rubio-Abadal E, Ochoa S, Grasa Bello EM, Alonso Solís A, Rabella M, Berdun J, Hospedales M, M-Resist G, Corripio I, Usall J. Huerta-Ramos E, et al. Among authors: marco garcia s. Actas Esp Psiquiatr. 2017 Nov;45(6):277-89. Epub 2017 Nov 1. Actas Esp Psiquiatr. 2017. PMID: 29199762 Free article.